402 related articles for article (PubMed ID: 18174523)
1. mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes.
Fraenkel M; Ketzinel-Gilad M; Ariav Y; Pappo O; Karaca M; Castel J; Berthault MF; Magnan C; Cerasi E; Kaiser N; Leibowitz G
Diabetes; 2008 Apr; 57(4):945-57. PubMed ID: 18174523
[TBL] [Abstract][Full Text] [Related]
2. Defective stimulus-secretion coupling in islets of Psammomys obesus, an animal model for type 2 diabetes.
Nesher R; Warwar N; Khan A; Efendic S; Cerasi E; Kaiser N
Diabetes; 2001 Feb; 50(2):308-14. PubMed ID: 11272141
[TBL] [Abstract][Full Text] [Related]
3. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
4. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
Khamzina L; Veilleux A; Bergeron S; Marette A
Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
[TBL] [Abstract][Full Text] [Related]
5. A chronic increase in physical activity inhibits fed-state mTOR/S6K1 signaling and reduces IRS-1 serine phosphorylation in rat skeletal muscle.
Glynn EL; Lujan HL; Kramer VJ; Drummond MJ; DiCarlo SE; Rasmussen BB
Appl Physiol Nutr Metab; 2008 Feb; 33(1):93-101. PubMed ID: 18347658
[TBL] [Abstract][Full Text] [Related]
6. Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway.
Kim JH; Kim JE; Liu HY; Cao W; Chen J
J Biol Chem; 2008 Jan; 283(2):708-15. PubMed ID: 17993646
[TBL] [Abstract][Full Text] [Related]
7. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
Fang CX; Yang X; Sreejayan N; Ren J
Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
[TBL] [Abstract][Full Text] [Related]
8. [Effect of AMPK/mTOR/S6K1 pathways and the insulin-sensitizing effect for adiponectin in endometrial cancer cells].
Cai ZF; Deng L; Wang MM; Zhang JQ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2018 Aug; 53(8):554-560. PubMed ID: 30138966
[No Abstract] [Full Text] [Related]
9. Balancing needs and means: the dilemma of the beta-cell in the modern world.
Leibowitz G; Kaiser N; Cerasi E
Diabetes Obes Metab; 2009 Nov; 11 Suppl 4():1-9. PubMed ID: 19817783
[TBL] [Abstract][Full Text] [Related]
10. Interaction between genetic and dietary factors determines beta-cell function in Psammomys obesus, an animal model of type 2 diabetes.
Nesher R; Gross DJ; Donath MY; Cerasi E; Kaiser N
Diabetes; 1999 Apr; 48(4):731-7. PubMed ID: 10102688
[TBL] [Abstract][Full Text] [Related]
11. Improved insulin sensitivity by rapamycin is associated with reduction of mTOR and S6K1 activities in L6 myotubes.
Hwang SL; Li X; Lee JY; Chang HW
Biochem Biophys Res Commun; 2012 Feb; 418(2):402-7. PubMed ID: 22281494
[TBL] [Abstract][Full Text] [Related]
12. Nutritionally induced diabetes in desert rodents as models of type 2 diabetes: Acomys cahirinus (spiny mice) and Psammomys obesus (desert gerbil).
Shafrir E; Ziv E; Kalman R
ILAR J; 2006; 47(3):212-24. PubMed ID: 16804196
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes.
Yuan T; Rafizadeh S; Gorrepati KD; Lupse B; Oberholzer J; Maedler K; Ardestani A
Diabetologia; 2017 Apr; 60(4):668-678. PubMed ID: 28004151
[TBL] [Abstract][Full Text] [Related]
14. Cardamonin ameliorates insulin resistance induced by high insulin and high glucose through the mTOR and signal pathway.
Niu P; Zhang Y; Shi D; Chen Y; Deng J
Planta Med; 2013 Apr; 79(6):452-8. PubMed ID: 23512499
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes.
Donath MY; Gross DJ; Cerasi E; Kaiser N
Diabetes; 1999 Apr; 48(4):738-44. PubMed ID: 10102689
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical effect of rapamycin on inflammatory stress-induced insulin resistance in vitro and in vivo.
Yang P; Zhao Y; Zhao L; Yuan J; Chen Y; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
Sci Rep; 2015 Oct; 5():14959. PubMed ID: 26449763
[TBL] [Abstract][Full Text] [Related]
17. beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes.
Leibowitz G; Yuli M; Donath MY; Nesher R; Melloul D; Cerasi E; Gross DJ; Kaiser N
Diabetes; 2001 Feb; 50 Suppl 1():S113-7. PubMed ID: 11272167
[TBL] [Abstract][Full Text] [Related]
18. PPARγ activation attenuates glucose intolerance induced by mTOR inhibition with rapamycin in rats.
Festuccia WT; Blanchard PG; Belchior T; Chimin P; Paschoal VA; Magdalon J; Hirabara SM; Simões D; St-Pierre P; Carpinelli A; Marette A; Deshaies Y
Am J Physiol Endocrinol Metab; 2014 May; 306(9):E1046-54. PubMed ID: 24619883
[TBL] [Abstract][Full Text] [Related]
19. Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets.
Kwon G; Marshall CA; Pappan KL; Remedi MS; McDaniel ML
Diabetes; 2004 Dec; 53 Suppl 3():S225-32. PubMed ID: 15561916
[TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
